about
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and i...
Read More
2.00
0.09
(4.71%)
3.0M
XNAS Volume
XNAS 24 Mar, 2026 4:19 PM (EDT)
Board Meeting
The board meeting for Palisade Bio Inc is scheduled for today, for the purpose of Palisade Bio Inc Annual Report for 2025
See details
Not Eligible
Expensive Valuation
Technically Bullish
Palisade Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..